Enterprise AutomationIndustries

Eli Lilly Accelerates Drug Discovery With Agentic Workflows

Research teams orchestrate agents to mine literature, propose candidate molecules and design experiments, compressing early-stage discovery cycles.

BioBriefEli LillyDEMO
Eli Lilly Accelerates Drug Discovery With Agentic Workflows

Analysis

Agents act as tireless research associates: gathering evidence, maintaining a living hypothesis graph and flagging contradictions for scientists to resolve.

Why it matters

Discovery is a long-cycle, high-value problem where even modest acceleration compounds into significant pipeline value over time.

#healthcare#drug discovery#case study

Source: BioBrief